RPTX Message Board Post 10054492 | Repare Therapeutics Inc.
home / stock / rptx / rptx message board
freyrsolutions
(investorshub)
Posted on: Jun/08/2022 15:12:26
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=169088424
I believe we going to break 15 on
News, Short Squeeze, Breakout and More Instantly...
-
Overall response of 18.2% in heavily pretreated patients across gastrointestinal tumors with target alterations regardless of prior irinotecan exposure Prolonged clinical benefit in patients with CRC, with 40% of irinotecan-naïve patients receiving treatment for greater than nine mon...
-
Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced the first patient has been dosed in the Company’s camonsertib monotherapy non-small cell lung cancer (NSCLC) expansion of th...
-
Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to lunresertib in combination with camonsertib for t...